18 November 2025 – In the frame of the ICPerMed Strategic Working Group on Internationalisation, a webinar will be organised on 20 November 2025 from 15:00-16:30 CET. Dr. Emmanouil (Manolis) Dermitzakis will introduce the Qatar Precision Health Institute.
If you are interested to join the webinar, please use te following link: https://anr.webex.com/anr-en/j.php?MTID=m853152767c9334a21dfbd1080b645184
Dr. Emmanouil (Manolis) Dermitzakis (Quatar)
Dr. Dermitzakis is the President of the Qatar Precision Health Institute. He is also co-founder and the CEO of Antithesis Therapeutics. Previously, he was Vice President and Head of Computational Biology at GSK as well as Professor of Genetics in the Department of Genetic Medicine and Development, University of Geneva Medical School.
This is the third event of a series of webinars with the aim to overall increase the awareness about Personalised Medicine and to share information about activities and successes in the field.